Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Application of Health Education Path of Traditional Chinese Medicine Nursin
- Status
- COMPLETED
- Phase
- NA
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE1
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers
- Status
- COMPLETED
- Phase
- N/A
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Psychological Mobile App for Patients With AML
- Status
- TERMINATED
- Phase
- NA
Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1